Search
Returning search results with filters:
Remove filter for
Audience: Retail
Remove filter for
Issue: Health products
Remove filter for
Type: Recall
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 13 of 13 items.
Medicinal Ingredients (active ingredients) on bottle label of affected lot may be illegible.
RecallHealth product recall | 2023-08-29
Affected lot has incorrect product image on the product label.
RecallHealth product recall | 2022-11-21
Product sold without market authorization (DIN) in Canada. All affected lots may contain bimatoprost, a prostaglandin analogue, which is listed on the prescription drug list. Test results for Lot 20220331 found the product to contain bimatoprost.…
RecallHealth product recall | 2022-09-26
Incorrect label (Riva-Oxazepam 30MG 500 tablets DIN00568414) may be appended to affected lots that contains: Riva-Oxazepam 15MG 500 tablets DIN00568406.
RecallHealth product recall | 2022-09-22
Out of Specification result for Finished Product Assay and/or Blend Uniformity
RecallHealth product recall | 2022-09-21
Out of specification result for Spheroids Dissolution Rate Profile (DRP)
RecallHealth product recall | 2022-09-21
The product lot did not meet product specification at end of shelf life.
RecallHealth product recall | 2022-09-02
The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets.
RecallHealth product recall | 2022-09-02
Jamp Pharma Corporation is recalling one lot (D10776B) of Jamp-Atorvastatin Calcium after one bottle labelled to contain 10 mg tablets of Jamp-Atorvastatin Calcium was found to contain 40 mg tablets of Jamp-Atorvastatin Calcium.
Pharmacists may not…
RecallHealth product recall | 2022-08-29
Pharmascience Inc. is recalling one lot of pms-Hydromorphone, 2 mg tablets, (lot 639268) as the bottles may contain hydromorphone tablets of a different strength (8 mg), meaning they contain higher amounts of hydromorphone. Products from the affected lot…
RecallHealth product recall | 2022-08-22
The dissolution for vitamin D3 is out of specification in the affected lots.
RecallHealth product recall | 2022-08-22
Product not manufactured to product specifications/licence and does not contain the required risk information.
RecallHealth product recall | 2022-08-19
All lots contain an undeclared ingredient (sildenafil) that is listed on the prescription drug list.
RecallHealth product recall | 2022-06-01